immune thrombocytopenia
Showing 1 - 25 of 125
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023
Immune Thrombocytopenia Trial (VIT D)
Not yet recruiting
- Immune Thrombocytopenia
- VIT D
- (no location specified)
Oct 5, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023
Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)
Recruiting
- Immune Thrombocytopenia
- Baricitinib 2 MG
- Dexamethasone
-
Beijing, China
- +9 more
Jul 11, 2023
Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in France (data collection)
Recruiting
- Immune Thrombocytopenia
- +2 more
- data collection
-
Amiens, France
- +8 more
Jul 7, 2023
Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)
Enrolling by invitation
- Refractory Systemic Lupus Erythematosus
- +2 more
- CNCT19 cell injection
-
Peking, ChinaXiaofeng Zeng
Jul 3, 2023
Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,
Recruiting
- Autoimmune Hemolytic Anemia
- +5 more
- cytokine essays
- +6 more
-
Milano, ItalyFondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023
Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG [Olumiant], Danazol)
Not yet recruiting
- Immune Thrombocytopenia
- Baricitinib 2 MG [Olumiant]
- Danazol
-
Beijing, Beijing, China
- +9 more
May 2, 2023
Immune Thrombocytopenia Trial (peripheral blood and bone marrow withdrawal)
Not yet recruiting
- Immune Thrombocytopenia
- peripheral blood and bone marrow withdrawal
- (no location specified)
Jan 12, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (CM313 Injection)
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- CM313 Injection
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 12, 2023
Immune Thrombocytopenia Trial in Japan (Avatrombopag Oral Tablet)
Recruiting
- Immune Thrombocytopenia
- Avatrombopag Oral Tablet
-
Toyohashi, Aichi, Japan
- +18 more
Jan 11, 2023
Functional Activity of Platelets for Differential Diagnosis of
Not yet recruiting
- Immune Thrombocytopenia
- +3 more
- Flow cytometry
- Platelet aggregation and plasma coagulation
- (no location specified)
Dec 8, 2022
Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin
Not yet recruiting
- Immune Thrombocytopenia
- Pregnancy Related
- intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
- intravenous immunoglobulin
- (no location specified)
Dec 1, 2022
Immune Thrombocytopenia Trial in Worldwide (Rilzabrutinib, Placebo)
Recruiting
- Immune Thrombocytopenia
- Rilzabrutinib
- Placebo
-
Los Angeles, California
- +128 more
Nov 3, 2022
Immune Thrombocytopenia Trial in Bristol (Mycophenolate Mofetil, Prednisolone)
Completed
- Immune Thrombocytopenia
- Mycophenolate Mofetil
- Prednisolone
-
Bristol, United KingdomUniversity Hospital Bristol NHS Foundation Trust
Oct 25, 2022
Immune Thrombocytopenia Trial in Korea, Republic of (LIV-GAMMA SN Inj.10%)
Completed
- Immune Thrombocytopenia
- LIV-GAMMA SN Inj.10%
-
Busan, Korea, Republic of
- +10 more
Sep 30, 2022
Immune Thrombocytopenia Trial (Daratumumab Injection)
Not yet recruiting
- Immune Thrombocytopenia
- Daratumumab Injection
- (no location specified)
Sep 28, 2022
ITP, Immune Thrombocytopenia Trial in Beijing (Baricitinib)
Recruiting
- ITP
- Immune Thrombocytopenia
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Sep 27, 2022
Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in Graz (potential biomarkers)
Recruiting
- Immune Thrombocytopenia
- +3 more
- potential biomarkers
-
Graz, Styria, AustriaPediatric Hematology-Oncology Outpatient Clinic
Sep 8, 2022
Course of COVID-19 in Prior, Ongoing or de Novo ITP. Evaluation
Recruiting
- Immune Thrombocytopenia
- +3 more
-
Brescia, Italy
- +7 more
Aug 24, 2022